IRMD — IRADIMED CORP
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Dividends
⚠ Includes an irregular or special distribution — this yield is unlikely to repeat.
Measured signals that fired on IRMD
| date | signal | measured base rate |
|---|---|---|
| 2026-08-14 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-07-01 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-04-07 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-06-20 | GLENN JOHN CFO | Shares withheld for tax | 2.3K | 92.20 | 213.8K |
| 2026-06-20 | GLENN JOHN CFO | Option exercise | 5.8K | — | — |
| 2026-06-04 | Scharen-Guivel Hilda Frederique Director | Open-market sale | 1.8K | 95.00 | 167.8K |
| 2026-06-04 | Scharen-Guivel Hilda Frederique Director | Open-market sale | 1.2K | 95.00 | 117.2K |
| 2026-06-01 | Susi Roger E. CEO, President, Chairman | Open-market sale 10b5-1 plan | 924 | 91.91 | 84.9K |
| 2026-06-01 | Susi Roger E. CEO, President, Chairman | Open-market sale 10b5-1 plan | 775 | 89.79 | 69.6K |
| 2026-06-01 | Susi Roger E. CEO, President, Chairman | Open-market sale 10b5-1 plan | 401 | 91.08 | 36.5K |
| 2026-06-01 | Susi Roger E. CEO, President, Chairman | Open-market sale 10b5-1 plan | 400 | 88.68 | 35.5K |
| 2026-05-27 | Susi Roger E. CEO, President, Chairman | Open-market sale 10b5-1 plan | 2.2K | 91.85 | 199.0K |
| 2026-05-27 | Susi Roger E. CEO, President, Chairman | Open-market sale 10b5-1 plan | 333 | 92.61 | 30.8K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 93.2M | 967.8K |
| RENAISSANCE TECHNOLOGIES LLC | 42.4M | 440.7K |
| Copeland Capital Management, LLC | 34.6M | 359.3K |
| VANGUARD CAPITAL MANAGEMENT LLC | 34.5M | 358.6K |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 33.6M | 349.3K |
| Nine Ten Capital Management LLC | 32.2M | 334.5K |
| GEODE CAPITAL MANAGEMENT, LLC | 27.6M | 286.6K |
| DIMENSIONAL FUND ADVISORS LP | 21.8M | 226.1K |
| STATE STREET CORP | 19.7M | 204.5K |
| GOLDMAN SACHS GROUP INC | 19.1M | 197.9K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Iradimed Corp (IRMD) filed form 8-K/A · 2026-08-18 · SEC EDGAR
Others in Healthcare
Ask the AI about IRMD
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →